Douglas Baum
Director/Board Member presso Regent GLSC Technologies, Inc.
Patrimonio netto: 3 M $ in data 31/03/2024
Profilo
Mr. Douglas R.
Baum is on the Board of Directors at Regent GLSC Technologies, Inc. Mr. Baum was previously employed as a President, Chief Executive Officer & Director by Xeris Pharmaceuticals, Inc., a Chief Executive Officer & Director by QSAM Biosciences, Inc., a Chief Operating Officer & Executive Vice President by MacuCLEAR, Inc., a Vice President-Global Business Development by Premier Research Group Ltd., a Senior Vice President-Business Development by Relmada Therapeutics, Inc. /Old/, and a Director-Business Development by SCIREX Corp.
He also served on the board at Halsa Pharmaceuticals, Inc., Regent Technologies, Inc. and Texas Medical Device Alliance, Inc. He received his undergraduate degree from The University of Texas at Austin and a graduate degree from The University of Texas at Austin.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
8.48% | 08/04/2024 | 376 849 ( 8.48% ) | 3 M $ | 31/03/2024 |
| 06/02/2024 | 684 ( 36.99% ) | 5 130 $ | 31/03/2024 |
Posizioni attive di Douglas Baum
| Società | Posizione | Inizio |
|---|---|---|
Regent GLSC Technologies, Inc.
 Regent GLSC Technologies, Inc. Medical SpecialtiesHealth Technology Part of Regent Technologies, Inc., Regent GLSC Technologies, Inc. is a private company that manufactures medical equipment. The company is based in Dallas, TX. David Arthur Nelson has been the CEO of the company since 2007. | Director/Board Member | 11/10/2010 |
Precedenti posizioni note di Douglas Baum
| Società | Posizione | Fine |
|---|---|---|
| QSAM BIOSCIENCES, INC. | Founder | 02/05/2024 |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Chief Executive Officer | 09/01/2017 |
| REGENT TECHNOLOGIES INC | Director/Board Member | - |
| Texas Medical Device Alliance, Inc. | Director/Board Member | - |
| Halsa Pharmaceuticals, Inc. | Director/Board Member | - |
Formazione di Douglas Baum
| The University of Texas at Austin | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Regent Technologies, Inc.
 Regent Technologies, Inc. SemiconductorsElectronic Technology Regent Technologies, Inc. engages in the provision of energy solutions. It develops backup electricity systems for residential and light industrial. The company was founded on January 18, 1980 and is headquartered in Dallas, TX. | Electronic Technology |
Premier Research Group Ltd.
 Premier Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Premier Research Group Ltd. provides contract research services to pharmaceutical industry. It engages in analgesics, neuroscience, medical devices, rare diseases and pediatrics. The company offers pediatric experience with both familiar and extremely rare childhood illnesses, including work at PICUs, NICUs, clinics, ERs and neonatal studies. Premier Research Group was founded in 2002 and is headquartered in Wokingham, the United Kingdom. | Commercial Services |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Health Technology |
| SCIREX Corp. | Commercial Services |
Relmada Therapeutics, Inc. /Old/
 Relmada Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Relmada Therapeutics, Inc. is a holding company, which engages in the development of pharmaceutical drugs for the treatment of acute and chronic pains. It focuses in the developing of chronic pain due to cancer, musculoskeletal disorders, and peripheral neuropathy. The company was founded in 2000 and is headquartered in Blue Bell, PA. | Health Technology |
MacuCLEAR, Inc.
 MacuCLEAR, Inc. Pharmaceuticals: MajorHealth Technology MacuCLEAR, Inc. manufactures pharmaceutical products for vascular eye disorders. The company was founded by George C. Y. Chiou and is headquartered in Richardson, TX. | Health Technology |
Regent GLSC Technologies, Inc.
Regent GLSC Technologies, Inc. Medical SpecialtiesHealth Technology Part of Regent Technologies, Inc., Regent GLSC Technologies, Inc. is a private company that manufactures medical equipment. The company is based in Dallas, TX. David Arthur Nelson has been the CEO of the company since 2007. | Health Technology |
| Halsa Pharmaceuticals, Inc. | |
| QSAM Biosciences, Inc. | |
| Texas Medical Device Alliance, Inc. |
- Borsa valori
- Insiders
- Douglas Baum
